GGrantIndex
Sort

50,496 grants matching lung cancer

A novel flat-panel detector for advanced on-board radiation therapy imaging

$565,608
Ross I. Berbeco · Dana-Farber Cancer Inst · R01 · FY2024 · CA

Image-guided TRAIL-enhanced CAR T-cell immunotherapy

$565,587
Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

Characterization and modeling of m6A RNA methylation in cancer

$565,529
Han Liang · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Electronic cigarette derived free radicals, oxidative stress and inflammation in lung cancer development

$565,464
Jay Louis Zweier · Ohio State University · R01 · FY2022 · CA

Electronic cigarette derived free radicals, oxidative stress and inflammation in lung cancer development

$565,464
Jay Louis Zweier · Ohio State University · R01 · FY2025 · CA

Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung

$565,375
Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Genotyping for epidemiology studies

$565,346
Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA

New Electrographic Biomarkers of Epileptogenesis

$565,274
Anatol Bragin · University Of California Los Angeles · R01 · FY2018 · NS

CNS Gene Delivery and Imaging in brain Tumor Therapy

$565,271
Oregon Health And Science University · R01 · FY2005 · NS

Adeno-associated virus-mediated SGPL1 gene therapy as a first-in-class treatment for idiopathic pulmonary fibrosis that acts by reducing sphingosine-1-phosphate and downstream profibrotic signaling

$565,250
Julie D Saba · University Of California, San Francisco · R61 · FY2025 · HL

Serum pro-N-cadherin as an early biomarker of radiation-induced heart disease

$565,250
Chang-Lung Lee · Duke University · U01 · FY2025 · AI

Adeno-associated virus-mediated SGPL1 gene therapy as a first-in-class treatment for idiopathic pulmonary fibrosis that acts by reducing sphingosine-1-phosphate and downstream profibrotic signaling

$565,250
Julie D Saba · University Of California, San Francisco · R61 · FY2024 · HL

Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (APNEA

$565,224
Kevin R Krull · St. Jude Children'S Research Hospital · R01 · FY2021 · CA

(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression

$565,095
Sidi Chen · Yale University · R01 · FY2022 · CA

Therapeutic implication of CD38 in CLL

$565,086
Eduardo N Chini · Mayo Clinic Jacksonville · R01 · FY2023 · CA

Development Of Drugs Acting At Adenosine Receptors

$565,028
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK

African American Families Fighting Parental Cancer Together

$564,992
Adam Davey · University Of Delaware · R01 · FY2019 · CA

Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository

$564,986
Chu Chen · Fred Hutchinson Cancer Research Center · U01 · FY2018 · CA

Molecular and Genetic Analysis of Lung Cancer Survival

$564,959
Harvard University (Sch Of Public Hlth) · R01 · FY2005 · CA

Molecular mechanisms underlying lineage plasticity in prostate cancer

$564,876
Himisha Beltran · Dana-Farber Cancer Inst · R37 · FY2024 · CA

The role of Galectin-1 in shaping the immune suppressive landscape in head and neck cancer

$564,874
Quynh-Thu X Le · Stanford University · R01 · FY2024 · DE

Modeling the SCLC Phenotypic Space

$564,861
Vito Quaranta · Vanderbilt University · U54 · FY2018 · CA

Personalizing NSCLC Therapy: Exploiting KRAS activated pathways

$564,855
Roy S Herbst · Yale University · R01 · FY2012 · CA

Engineered Nanoformulation for Immune-modulation in Cancer

$564,843
Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · CA

VEGF-based Targeted Imaging of Tumor Vasculature

$564,762
Joseph M Backer · Sibtech, Inc. · R44 · FY2008 · CA